CT perfusion-guided patient selection for endovascular recanalization in acute schemic stroke: A multicenter study

Journal of NeuroInterventional Surgery

Volumn 5, Issue 6, 2013, Pages 523-527

  Turk, Aquilla S ^a   Asher Magarick, Jordan ^a   Frei, Don ^b   Michael Fargen, Kyle ^c   Chaudry, Imran ^a   Holmstedt, Christine A ^a   Nicholas, Joyce ^a   Mocco, J ^d   Turner, Raymond D ^a   Huddle, Daniel ^b   Loy, David ^b   Bellon, Richard ^b   Dooley, Gwendolyn ^b   Adams, Robert ^a   Whaley, Michelle ^b   Fanale, Chris ^b   Jauch, Edward ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Radiology Imaging Associates   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOSE RESPONSE; ENDOVASCULAR SURGERY; FEMALE; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT SAFETY; PATIENT SELECTION; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY;

STROKE;

AGED; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; DATA INTERPRETATION, STATISTICAL; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; PATIENT SELECTION; PERFUSION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STROKE; SURGERY, COMPUTER-ASSISTED; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84885334315     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2012-010491     Document Type: Article

References (36)

1. The National Institute of Neurological Disorders and stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
2. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
3. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
4. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51. (Pubitemid 28470336)
5. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127-35.
6. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-711. (Pubitemid 46691097)
7. Furlan A, Higashida R, Wechsler L, et al. Intra-Arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11.
8. Lin R, Vora N, Zaidi S, et al. Mechanical approaches combined with intra-Arterial pharmacological therapy are associated with higher recanalization rates than either intervention alone in revascularization of acute carotid terminus occlusion. Stroke 2009;40:2092-7.
9. Shi ZS, Loh Y, Walker G, et al. Clinical outcomes in middle cerebral artery trunk occlusions versus secondary division occlusions after mechanical thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and multi MERCI trials. Stroke 2010;41:953-60.
10. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-8. (Pubitemid 40967507)
11. Eastwood JD, Lev MH, Wintermark M, et al. Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. AJNR Am J Neuroradiol 2003;24:1869-75. (Pubitemid 37280539)
12. Wintermark M, Maeder P, Thiran JP, et al. Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models. Eur Radiol 2001;11:1220-30. (Pubitemid 32755601)
13. Wintermark M, Reichhart M, Thiran JP, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002;51:417-32. (Pubitemid 34260772)
14. Abou-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke 2010;41:1996-2000.
15. Koenig M, Kraus M, Theek C, et al. Quantitative assessment of the ischemic brain by means of perfusion-related parameters derived from perfusion CT. Stroke 2001;32:431-7. (Pubitemid 32155230)
16. Kohrmann M, Juttler E, Fiebach JB, et al. MRI versus CT-based thrombolysis treatment within and beyond the 3h time window after stroke onset: a cohort study. Lancet Neurol 2006;5:661-7. (Pubitemid 44062409)
17. Schellinger PD, Thomalla G, Fiehler J, et al. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke 2007;38:2640-5. (Pubitemid 47493997)
18. Turk A, Magarik JA, Chaudry I, et al. CT perfusion-guided patient selection for endovascular treatment of acute ischemic stroke is safe and effective. J Neurointervent Surg 2012;4:261-5.
19. Wintermark M, Flanders AE, Velthuis B, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006;37:979-85.
20. Mishra NK, Albers GW, Davis SM, et al. Mismatch-based delayed thrombolysis: a meta-Analysis. Stroke 2010;41:e25-33.
21. Nogueira RG, Smith WS. Emergency treatment of acute ischemic stroke: expanding the time window. Curr Treat Options Neurol 2009;11:433-43.
22. Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-8.
23. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-12. (Pubitemid 351440692)
24. Kleindorfer D, Kissela B, Schneider A, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke 2004;35:e27-9.
25. Christou I, Felberg RA, Demchuk AM, et al. Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging 2002;12:119-23. (Pubitemid 34252426)
26. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-Analysis. Stroke 2007;38:967-73. (Pubitemid 46568460)
27. Alvarez-Sabin J, Molina CA, Montaner J, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 2003;34:1235-41.
28. Kent TA, Mandava P. Recanalization rates can be misleading. Stroke 2007;38:e103. author reply e04.
29. Martini SR, Hill MD, Alexandrov AV, et al. Outcome in hyperglycemic stroke with ultrasound-Augmented thrombolytic therapy. Neurology 2006;67:700-2. (Pubitemid 44273626)
30. Rowley HA, Roberts TP. Clinical perspectives in perfusion: neuroradiologic applications. Top Magn Reson Imaging 2004;15:28-40. (Pubitemid 38437543)
31. De Silva DA, Brekenfeld C, Ebinger M, et al. The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 2010;41:295-9.
32. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73. (Pubitemid 40054177)
33. Lansberg MG, Thijs VN, Hamilton S, et al. Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE. Stroke 2007;38:1826-30. (Pubitemid 46847254)
34. Natarajan SK, Snyder KV, Siddiqui AH, et al. Safety and effectiveness of endovascular therapy after 8 hours of acute ischemic stroke onset and wake-up strokes. Stroke 2009;40:3269-74.
35. Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009;8:326-33.
36. Juttler E, Schwab S, Schmiedek P, et al. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke 2007;38:2518-25. (Pubitemid 47329631)